Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Substitution modelling in life cycle assessment of municipal solid waste management.

Viau S, Majeau-Bettez G, Spreutels L, Legros R, Margni M, Samson R.

Waste Manag. 2020 Feb 1;102:795-803. doi: 10.1016/j.wasman.2019.11.042. Epub 2019 Dec 5.

PMID:
31812832
2.

A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells.

Viau S, Lagrange A, Chabrand L, Lorant J, Charrier M, Rouger K, Alvarez I, Eap S, Delorme B.

Cytotherapy. 2019 Jul;21(7):738-754. doi: 10.1016/j.jcyt.2019.04.053. Epub 2019 May 24.

PMID:
31133491
3.

Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells.

Viau S, Eap S, Chabrand L, Lagrange A, Delorme B.

Transfusion. 2019 Mar;59(3):1069-1079. doi: 10.1111/trf.15205. Epub 2019 Feb 21.

PMID:
30793328
4.

Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.

Saury C, Lardenois A, Schleder C, Leroux I, Lieubeau B, David L, Charrier M, Guével L, Viau S, Delorme B, Rouger K.

Stem Cell Res Ther. 2018 May 2;9(1):128. doi: 10.1186/s13287-018-0852-y.

5.

Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Lorant J, Saury C, Schleder C, Robriquet F, Lieubeau B, Négroni E, Leroux I, Chabrand L, Viau S, Babarit C, Ledevin M, Dubreil L, Hamel A, Magot A, Thorin C, Guevel L, Delorme B, Péréon Y, Butler-Browne G, Mouly V, Rouger K.

Mol Ther. 2018 Feb 7;26(2):618-633. doi: 10.1016/j.ymthe.2017.10.013. Epub 2017 Oct 20.

6.

Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.

Viau S, Chabrand L, Eap S, Lorant J, Rouger K, Goudaliez F, Sumian C, Delorme B.

PLoS One. 2017 Aug 1;12(8):e0181406. doi: 10.1371/journal.pone.0181406. eCollection 2017.

7.

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.

Petrova PS, Viller NN, Wong M, Pang X, Lin GH, Dodge K, Chai V, Chen H, Lee V, House V, Vigo NT, Jin D, Mutukura T, Charbonneau M, Truong T, Viau S, Johnson LD, Linderoth E, Sievers EL, Maleki Vareki S, Figueredo R, Pampillo M, Koropatnick J, Trudel S, Mbong N, Jin L, Wang JC, Uger RA.

Clin Cancer Res. 2017 Feb 15;23(4):1068-1079. doi: 10.1158/1078-0432.CCR-16-1700. Epub 2016 Nov 17.

8.

Polyunsaturated fatty acids induce modification in the lipid composition and the prostaglandin production of the conjunctival epithelium cells.

Viau S, Leclère L, Buteau B, Grégoire S, Acar N, Bron A, Creuzot-Garcher CP, Bretillon L, Joffre C.

Graefes Arch Clin Exp Ophthalmol. 2012 Feb;250(2):211-22. doi: 10.1007/s00417-011-1801-y. Epub 2011 Sep 6.

PMID:
21894532
9.

No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye.

Viau S, Pasquis B, Maire MA, Fourgeux C, Grégoire S, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C.

Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):547-57. doi: 10.1007/s00417-010-1576-6. Epub 2010 Dec 16.

PMID:
21161262
10.

Efficacy of surface sampling methods for different types of beryllium compounds.

Dufresne A, Mocanu T, Viau S, Perrault G, Dion C.

J Environ Monit. 2011 Jan;13(1):74-83. doi: 10.1039/c001105c. Epub 2010 Oct 28.

PMID:
20981383
11.

Is there enough evidence for evidence-based practice in occupational therapy?

Dirette D, Rozich A, Viau S.

Am J Occup Ther. 2009 Nov-Dec;63(6):782-6. Review. No abstract available.

PMID:
20092114
12.

Beryllium aerosol characteristics in the magnesium and aluminum transformation industry in Quebec: a comparison of four different sampling methodologies.

Dufresne A, Dion C, Viau S, Cloutier Y, Perrault G.

J Occup Environ Hyg. 2009 Nov;6(11):687-97. doi: 10.1080/15459620903249828.

PMID:
19757293
13.

A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis.

Huesca M, Lock LS, Khine AA, Viau S, Peralta R, Cukier IH, Jin H, Al-Qawasmeh RA, Lee Y, Wright J, Young A.

Mol Cancer Ther. 2009 Sep;8(9):2586-96. doi: 10.1158/1535-7163.MCT-08-1104. Epub 2009 Sep 15.

14.

Beryllium decontamination with different solvents on different structures.

Dufresne A, Dion C, Viau S, Perrault G.

Ann Occup Hyg. 2009 Oct;53(7):669-75. doi: 10.1093/annhyg/mep047. Epub 2009 Jul 15.

PMID:
19605417
15.

Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation.

Schnebelen C, Viau S, Grégoire S, Joffre C, Creuzot-Garcher CP, Bron AM, Bretillon L, Acar N.

Ophthalmic Res. 2009;41(4):216-24. doi: 10.1159/000217726. Epub 2009 May 15.

PMID:
19451735
16.

Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model.

Viau S, Maire MA, Pasquis B, Grégoire S, Acar N, Bron AM, Bretillon L, Creuzot-Garcher CP, Joffre C.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1039-50. doi: 10.1007/s00417-009-1080-z. Epub 2009 May 5.

PMID:
19415319
17.

Solvent removal of beryllium from surfaces of equipment made of beryllium copper.

Dufresne A, Turcotte V, Golshahi H, Viau S, Perrault G, Dion C.

Ann Occup Hyg. 2009 Jun;53(4):353-62. doi: 10.1093/annhyg/mep007. Epub 2009 Mar 2.

PMID:
19254960
18.

GTI-2040 displays cooperative anti-tumor activity when combined with interferon alpha against human renal carcinoma xenografts.

Vassilakos A, Lee Y, Viau S, Feng N, Jin H, Chai V, Wang M, Avolio T, Wright J, Young A.

Int J Oncol. 2009 Jan;34(1):33-42.

PMID:
19082475
19.

11-Phenyl-[b,e]-dibenzazepine compounds: novel antitumor agents.

Al-Qawasmeh RA, Lee Y, Cao MY, Gu X, Viau S, Lightfoot J, Wright JA, Young AH.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):104-7. doi: 10.1016/j.bmcl.2008.11.001. Epub 2008 Nov 6.

PMID:
19027297
20.

Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.

Viau S, Maire MA, Pasquis B, Grégoire S, Fourgeux C, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C.

Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):857-67. doi: 10.1007/s00417-008-0784-9. Epub 2008 Mar 21.

PMID:
18357464
21.

Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye.

Joffre C, Souchier M, Grégoire S, Viau S, Bretillon L, Acar N, Bron AM, Creuzot-Garcher C.

Br J Ophthalmol. 2008 Jan;92(1):116-9.

PMID:
18156378
22.

[Improvement of dry eye symptoms with polyunsaturated fatty acids].

Creuzot C, Passemard M, Viau S, Joffre C, Pouliquen P, Elena PP, Bron A, Brignole F.

J Fr Ophtalmol. 2006 Oct;29(8):868-73. French.

PMID:
17075501
23.

Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxin.

Lee Y, Vassilakos A, Feng N, Avolio T, Jin H, Viau S, Wang M, Courssaris B, Xiong K, Wright J, Young A.

Anticancer Drugs. 2006 Feb;17(2):143-54.

PMID:
16428932
24.

Effects of neonatal hypoxia in the rat on inotropic stimulation of the adult heart.

Rohlicek CV, Viau S, Trieu P, Hébert TE.

Cardiovasc Res. 2005 Mar 1;65(4):861-8.

PMID:
15721866
25.

NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo.

Cao MY, Lee Y, Feng NP, Al-Qawasmeh RA, Viau S, Gu XP, Lau L, Jin H, Wang M, Vassilakos A, Wright JA, Young AH.

J Pharmacol Exp Ther. 2004 Feb;308(2):538-46. Epub 2003 Nov 10.

PMID:
14610220
26.

Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.

Cao MY, Lee Y, Feng NP, Xiong K, Jin H, Wang M, Vassilakos A, Viau S, Wright JA, Young AH.

Clin Cancer Res. 2003 Oct 1;9(12):4553-61.

27.

Effects of phosphoramidon, BQ 788, and BQ 123 on coronary and cardiac dysfunctions of the failing hamster heart.

Fontaine ER, Viau S, Jasmin G, Dumont L.

J Cardiovasc Pharmacol. 1998 Jul;32(1):12-20.

PMID:
9676715
28.
29.

Overexpression of vsr in Escherichia coli is mutagenic.

Doiron KM, Viau S, Koutroumanis M, Cupples CG.

J Bacteriol. 1996 Jul;178(14):4294-6.

31.

DoD seeking field material consistency.

Viau S.

US Med. 1982 Jul 1;18(13):1, 9. No abstract available.

PMID:
10259287
32.

CHAMPUS increasing, runs deficit.

Viau S.

US Med. 1982 Jun 15;18(12):2, 8. No abstract available.

PMID:
10324244
33.

Credentialing policy held in abeyance.

Viau S.

US Med. 1982 Jun 15;18(12):1, 11-2. No abstract available.

PMID:
10259285
34.

Hospital ships remain off schedule.

Viau S.

US Med. 1982 Jun 1;18(11):1, 4-5. No abstract available.

PMID:
10259284
35.

Lewisburg: a dichotomy of tradition, progress.

Viau S.

US Med. 1982 May 1;18(9):2, 18-20. No abstract available.

PMID:
10255403
36.

DoD physicians. New policy poses legal quandary.

Viau S.

US Med. 1982 Apr 15;18(8):1, 38-9. No abstract available.

PMID:
10324252
37.

Navy's are not: Marine units funded.

Viau S.

US Med. 1982 Jan 1;18(1):3, 30. No abstract available.

PMID:
10253985
38.

New AF field shelters not CBW-proof.

Viau S.

US Med. 1981 Nov 15;17(22):1, 18-9. No abstract available.

PMID:
10253683
39.

'Model' for states compares costs of retaining or closing hospitals.

Viau S.

US Med. 1981 Sep 1;17(17):19. No abstract available.

PMID:
10309447
40.

Military hospitals care for fewer, but technology demand seen up.

Viau S.

US Med. 1981 Apr 15;16(8):3, 26-7. No abstract available.

PMID:
10251208
41.

Standardized CPR kit follows 7-year effort.

Viau S.

US Med. 1980 Nov 15;16(22):4. No abstract available.

PMID:
10249492
42.

Disposal reservation restrictions pose problem for some hospitals.

Viau S, Jemison TL.

US Med. 1980 Aug 1;16(15):2, 12-3. No abstract available.

PMID:
10247785
43.

Some refugees suffer contagious diseases.

Viau S.

US Med. 1980 Jun 1;16(11):3, 26. No abstract available.

PMID:
10247019
44.

Agencies experimenting with fringe benefits: individual facilities decide which services to offer.

Viau S.

US Med. 1980 May 15;16(10):3, 36. No abstract available.

PMID:
10324084
45.

Groups in San Diego fighting Navy hospital.

Viau S.

US Med. 1980 Mar 15;16(5):3, 20. No abstract available.

PMID:
10324068
46.

Offspring neglected: proper pre-natal care, treatment of pregnant drug addicts lacking.

Viau S.

US Med. 1980 Mar 15;16(5):34-5. No abstract available.

PMID:
10316954

Supplemental Content

Support Center